Advertisement
Screener

LEXARIA BIOSCIENCE CORP. (LEXX) Executive Pay versus Performance: Pay versus Performance

LEXARIA BIOSCIENCE CORP. Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

  • 2025-08-31: PEO Richard Christopher; PEO total compensation $893.30K; PEO compensation actually paid $496.75K; Other NEO average total compensation $385.95K.
  • 2024-08-31: PEO total compensation $1.40M; PEO compensation actually paid $1.67M; Other NEO average total compensation $296.33K.
  • 2023-08-31: PEO total compensation $287.63K; PEO compensation actually paid $156.94K; Other NEO average total compensation $237.19K.
Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed
2025-08-31Richard Christopher$893.30K$496.75K$385.95K$279.56K$-77490.002025-12-10
2024-08-31$1.40M$1.67M$296.33K$340.45K$272380.002025-12-10
2023-08-31$287.63K$156.94K$237.19K$140.48K$-64530.002025-12-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Rallybio Corp (RLYB)United States$0.089B
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30